Panel recommends permission to Serum Institute for phase 2, 3 human clinical trials of Oxford vaccine candidate

Panel recommends permission to Serum Institute for phase 2, 3 human clinical trials of Oxford vaccine candidate

IndiaTimes

Published

A subject expert committee on Covid-19 on Friday recommended to the country's drug regulator that permission be granted to Serum Institute of India (SII) for conducting the second and third phases of human clinical trials of the Oxford vaccine candidate.

Full Article